Partnership for Cures

Delivering More Treatments to More Patients More Quickly

aka Cures Within Reach   |   CHICAGO, IL   |  www.cureswithinreach.org

Mission

Cures Within Reach improves patient quality and length of life by leveraging the unrealized clinical potential and missed therapeutic opportunities of existing medicine and science. We leverage the speed, safety and cost-effectiveness of medical repurposing research, driving more treatments to more patients more quickly by clinically testing approved drugs, devices and nutraceuticals for unsolved disease indications that serve commercial and/or philanthropic need.

Notes from the nonprofit

The more we work together, the sooner we can drive more treatments to more patients more quickly through Repurposing Research.

Ruling year info

2005

President and CEO

Barbara Goodman

Main address

134 N. LaSalle St #1130

CHICAGO, IL 60602 USA

Show more contact info

EIN

20-3620169

NTEE code info

Medical Specialty Research (H90)

Fund Raising and/or Fund Distribution (G12)

Research Institutes and/or Public Policy Analysis (E05)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2020, 2019 and 2018.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Cures Within Reach’s mission is to improve patient quality and length of life by leveraging the speed, safety and cost-effectiveness of testing already approved therapies for new indications that serve philanthropic and/or commercial uses, driving more treatments to more patients more quickly.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Proof of Concept Clinical Trials

These studies test new hypotheses for disease treatment and require initial funding of $35,000-100,000. They include pilot clinical trials in unsolved disease testing drugs, devices, nutraceuticals and diagnostics already approved for human use.

Population(s) Served
People with diseases and illnesses

CureAccelerator is the World’s First Online, Interactive Platform
 For Repurposing Research. CureAccelerator supports "proof of concept” research repurposing drugs, devices and nutriceuticals already approved for human use. On CureAccelerator, funders have direct access to repurposing research, researchers can post ideas and connect with peers and funding, and clinicians can contribute their experience of off-label use in need of validation. Using expertise, resources and dollars on hand, CureAccelerator is here so that we can all quickly and affordably answer the question "will this help patients?”

Population(s) Served
People with diseases and illnesses

Where we work

Awards

Fellowship in Social Entrepreneurship 2009

Ashoka

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Estimated number of funding dollars secured for the sector

This metric is no longer tracked.
Totals By Year
Related Program

Proof of Concept Clinical Trials

Type of Metric

Outcome - describing the effects on people or issues

Direction of Success

Holding steady

Context Notes

In 2021, $9 million in new funding was raised by our researchers for ongoing trials or next phase trials.

Number of demonstration project or pilot sites

This metric is no longer tracked.
Totals By Year
Population(s) Served

People with diseases and illnesses

Related Program

Proof of Concept Clinical Trials

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

In 2021, we selected 16 new trials for funding.

Number of volunteers

This metric is no longer tracked.
Totals By Year
Population(s) Served

People with diseases and illnesses

Related Program

Proof of Concept Clinical Trials

Type of Metric

Input - describing resources we use

Direction of Success

Increasing

Context Notes

In 2021, more than 85 volunteer Grant Review Committee members, representing research, clinicians, industry and the patient / community voice, helped us review and select our funded trials.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Our goal: funding the projects that, when successful, will catalyze follow-on funding and/or further trials and publications. We focus on patient access to viable treatments, regardless of whether there may be a philanthropic opportunity or commercial value to treat patients with unmet medical needs.

Cures Within Reach’s Repurposing Communities: Disease Areas, Geographies, Population Groups

In 2019, Cures Within Reach launched Repurposing Communities to provide strategic alignment among our many stakeholder groups within disease-specific and geographic areas of interests. Engagement by all our stakeholder groups can be enhanced within the specific community as well as through CWR central organization, including patient groups and disease associations, universities and research institutions, healthcare industry and service providers, philanthropy, and government / others.

In 2021, we expanded into population groups, adding Pediatrics, Veterans & Military, and Minority & Underserved (DEI) areas of interests.

Our Disease-Specific Communities
Neurology (including mental health and neurodegenerative)
Oncology
Rare diseases

Our Geographic-Specific Communities
Chicago
The Mid-Atlantic (includes Washington DC, VA, MD, DE and parts of PA)
The Developing World (includes low and lower-middle income countries, per the World Bank)

Our Patient Population Communities
Pediatrics
Veterans and Active Military
Minority and Underserved within Diversity, Equity & Inclusion (includes health disparities, patients and researchers)

For over a decade, Cures Within Reach has found and funded over 100 repurposing research projects in over 60 institutions in 60 different diseases. This has resulted in supporting research that found 13 repurposed therapies for children with deadly diseases ALPS and FD, adults with multiple sclerosis, lung cancer, blood cancer, myelodysplastic syndrome and prostate cancer, and adult and children with type 1 and type 2 diabetes. Our $7 million in funding has helped to catalyze more than $76 million in follow-on funding - a strong leverage metric. We have a strong platform called CureAccelerator™ where researchers and clinicians submit their clinical repurposing research ideas for funding.

Financials

Partnership for Cures
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Partnership for Cures

Board of directors
as of 03/11/2022
SOURCE: Self-reported by organization
Board chair

Margaret Christie

Margaret Christie

Golan Christie Taglia, LLC

Steve Braun

Northwestern Mutual Financial Network

Matt Rich

PWC

David Styler

Horizon Therapeutics

Lucy Mancini-Newell

Rob Metz

Armour Life Sciences

Nancy Sullivan

Illinois Ventures

Kristina Allikments

Takeda Pharma

Nicholas Manusos

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes

Organizational demographics

SOURCE: Self-reported; last updated 1/5/2021

Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female
Sexual orientation
Heterosexual or Straight
Disability status
Person without a disability

Race & ethnicity

No data

Gender identity

 

Sexual orientation

No data

Disability